Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
7 March 2016 | Informations
GUINEAOPERATIONAL RESEARCHInfectious and emerging diseases
Congratulations to INSERM and other partners of the JIKI trial, among which Alima, Doctors w/borders, the Red Cross for this publication in Plosmedicine
The JIKI clinical trial seeked to test the effectiveness of Favirapir among people infected with the Ebola virus in Guinea.
Solthis is pleased to have been able to participate in a modest degree to this project by facilitating the achievement of this trial on the spot through its team based in Conaky.
